Get the Daily Brief
Latest Biotech News
Illumina and Oxford Nanopore Leaders Discuss Genomics Advances
Leaders from key genomics companies shared insights into the evolving landscape of next-generation sequencing (NGS) and multiomics. Jacob Thaysen, CEO of Illumina, outlined his vision for...
Multiomics and Single-Cell Genomics Revolutionizing Biology
Multiomics and single-cell genomics techniques are transforming biological research and precision medicine. Experts at GEN’s virtual summit detailed how spatial proteomics is enhancing...
Expansion of Long-Read Sequencing Projects Enhances Genomic Resolution
Efforts to deepen and broaden long-read sequencing in the landmark 1000 Genomes Project have gathered momentum. The consortium has incorporated Pacific Biosciences’ technologies alongside Oxford...
Regulatory and Clinical Updates Impacting Biopharma Pipelines
Multiple recent regulatory decisions and clinical trial updates are shaping biopharma pipelines. The FDA approved Leo Pharma’s Anzupgo, the first treatment for chronic hand eczema, expanding...
Venture Funding Trends and Market Dynamics in Biotech
Venture capital funding in biotechnology is exhibiting increasingly selective and competitive trends. The Biotechnology Innovation Organization's 2025 report highlights a contraction in newly...
AI Innovations Accelerate mRNA Drug and Vaccine Development
Artificial intelligence models are accelerating drug and vaccine discovery by enhancing understanding of mRNA translation efficiency and protein synthesis. Recent AI systems predict how mRNA...
Parkinson’s Disease: New Research on Pathways and Therapies
Emerging research is shedding light on Parkinson’s disease mechanisms and novel therapeutic strategies. Studies reveal that glymphatic system asymmetry correlates with the side of symptom onset,...
Discoveries in Plant Immunity and Sustainable Agriculture
Significant advances in plant biology highlight mechanisms of immunity and sustainable farming practices. Research in Arabidopsis has revealed a root-originating N-hydroxypipecolic acid (NHP)...
Sarepta’s Duchenne Gene Therapy Faces Regulatory Setbacks and Safety Concerns
Sarepta Therapeutics is embroiled in controversy surrounding its Duchenne muscular dystrophy gene therapy, Elevidys. The FDA has requested a voluntary shipment halt due to safety concerns linked...
Regulatory Delays and Developments Impact Biopharma Pipelines
Several biopharmaceutical companies are navigating ongoing regulatory challenges and approvals. GSK’s antibody-drug conjugate Blenrep, targeting multiple myeloma, faces continued FDA review delays...
Advances in AI and Computational Biology Propel Immunotherapy and Genomics
Innovations in artificial intelligence (AI) and computational methods are increasingly transforming biotechnology research and drug development. Cold Spring Harbor Laboratory introduced BATMAN, an...
Biopharma Financing and Venture Capital Landscape Shifts
Investment patterns in biotech reflect a more mature and selective market. Venture capital firms are concentrating larger sums into fewer companies, focusing on clinical-stage programs rather than...
Emerging Technologies and Research in Proteomics and Genomics
Innovative research is deepening understanding of biological complexity through proteomics and genomics. A comprehensive proteomic study identified tissue-specific aging patterns and a critical...
Biotech Executive Moves and Industry Leadership Transitions
Several biotechnology firms announced notable leadership changes and appointments. Bristol Myers Squibb named Cristian Massacesi, former AstraZeneca CMO, as its new chief medical officer effective...
Clinical Trial and Therapeutic Development Updates in Rare and Autoimmune Diseases
Research and clinical progress continue in multiple therapeutic areas. AstraZeneca’s gefurulimab, a complement C5 inhibitor, demonstrated positive phase III results in generalized myasthenia...
Industry Reports Indicate Challenges and Trends in Emerging Biotech Companies
The 2025 report from the Biotechnology Innovation Organization (BIO) reflects a challenging funding environment for emerging biotech firms post-COVID-19. Investments are concentrated among fewer...
Biotechnology Collaborations and Partnerships Accelerate Drug Discovery and Manufacturing
Strategic alliances are advancing pharmaceutical innovation and manufacturing capabilities globally. Eli Lilly partnered with Gate Bioscience to develop and commercialize molecular gate...
Corporate Restructuring and Workforce Adjustments in Gene Therapy Firms
Gene therapy-focused biotechs are realigning operations in response to financial and clinical challenges. Rocket Pharmaceuticals announced a 30% workforce reduction as part of efforts to reduce...
FDA Delays GSK’s Blenrep Decision Amid Dose Concerns
The FDA has postponed its approval decision for GlaxoSmithKline’s multiple myeloma therapy Blenrep to October 23, extending the review to assess additional data. This follows a negative advisory...
Sarepta Faces Regulatory and Safety Hurdles for Elevidys Gene Therapy
Sarepta Therapeutics is under intense scrutiny following multiple patient deaths associated with its Duchenne muscular dystrophy gene therapy, Elevidys. While initially pushing back on the FDA's...